Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
DualityBio and Genentech partner on next-generation ADCs in deal worth over $1 billion
43+ min ago (282+ words) August 31, 2026 | Monday | News The partnership is designed to develop ADCs with novel payload mechanisms that could address resistance to the payload classes used in currently approved ADC therapies. Under the agreement, DualityBio will lead discovery and early global clinical development…...
CanSinoBIO accelerates overseas growth as vaccine portfolio and mRNA pipeline expand
1+ hour ago (264+ words) August 31, 2026 | Monday | News The company recorded approximately RMB550 million in revenue for the period, an increase of 43.8% year-on-year, while its net loss attributable to shareholders narrowed significantly. Registration and commercialisation activities are progressing across Southeast Asia, South America and the Middle…...
Singapore designs bioinspired nanoparticles that deliver gene editing to lower bad cholesterol
4+ day, 22+ hour ago (265+ words) August 26, 2026 | Wednesday | News Researchers from the National University of Singapore (NUS) Medicine and China's Tianjin Medical University General Hospital have developed a bioinspired lipid nanoparticle (LNP) that can deliver gene-editing machinery to the liver and reduce low-density lipoprotein (LDL) cholesterol, commonly…...
China's Haisco Pharma enters into agreement worth $1.5 B with US-based Sentivera
4+ day, 22+ hour ago (240+ words) August 26, 2026 | Wednesday | News Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US venture founded by Population Health Partners (PHP) and ARCH Venture Partners, to grant Sentivera the rights to develop, manufacture, and commercialise…...
Korea's Hanmi Pharm signs $2.3 B deal with Genentech for novel obesity therapy
5+ day, 12+ hour ago (235+ words) August 25, 2026 | Tuesday | News South Korea-based Hanmi Pharm has entered into an exclusive licensing agreement with Genentech, a member of the Roche Group, for the development, manufacturing, and commercialisation of Hanmi's novel metabolic treatment candidate, HM17321 (UCN2), for obesity and associated conditions such…...
Deep Origin explores combining AI and physics to improve virtual screening in drug discovery
5+ day, 18+ hour ago (296+ words) August 25, 2026 | Tuesday | Opinion | By [email protected] Virtual screening has existed for decades, yet its use as a primary hit-finding strategy remains limited. Deep Origin is developing an approach that combines generative AI with physics-based molecular modelling, with the aim of…...
GC Biopharma's Hunter Syndrome treatment 'Hunterase' receives drug approval in India and Taiwan
6+ day, 10+ hour ago (230+ words) August 24, 2026 | Monday | News GC Biopharma, a leading global pharmaceutical company based in South Korea, has announced that its Hunter syndrome treatment, 'Hunterase IV', has received marketing authorisation from India's Central Drugs Standard Control Organisation (CDSCO) and Taiwan's Food and Drug…...
Charles River Laboratories collaborates with Taiwan's Medigen Vaccine Biologics Corp
6+ day, 10+ hour ago (100+ words) August 24, 2026 | Monday | News MVC's proprietary ENVACGEN® Enterovirus 71 Vaccine has been approved in Taiwan and Vietnam, demonstrating the company's proven capability to develop and manufacture vaccines that meet international quality standards. Building on this success, MVC is advancing the development of…...
Hong Kong Applied Science and Technology Research Institute advances AI-enabled biomaterials and digital health innovation
6+ day, 11+ hour ago (342+ words) BioSpectrum Asia Hong Kong Applied Science and Technology Research Institute advances AI-enabled biomaterials and digital health innovation August 24, 2026 | Monday | News Partnership with Saint Francis University to accelerate innovation, facilitate technology transfer, and nurture the next generation of talent in applied…...
China Biotech’s Global Breakout: Innovation, Deals and the Next Investment Cycle
6+ day, 15+ hour ago (344+ words) August 24, 2026 | Monday | Influencers | By Ankit Kankar | [email protected] China’s biotech and pharmaceutical sector is entering a new phase of global relevance. A surge in out-licensing deals, increasingly competitive innovation, improving financial performance and attractive valuations are drawing renewed investor attention to…...